Cargando…
Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection
Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is an inhibitor of inosine monophosphate dehydrogenase (IMPDH). It preferentially inhibits denovo pathway of guanosine nucleotide synthesis in T and B-lymphocytes and prevents their proliferation, thereby suppresses both cell mediate...
Autores principales: | Dalal, Pranav, Grafals, Monica, Chhabra, Darshika, Gallon, Lorenzo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697521/ https://www.ncbi.nlm.nih.gov/pubmed/19436616 |
Ejemplares similares
-
Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
por: Dalal, P, et al.
Publicado: (2010) -
Mycophenolate mofetil toxicity mimicking acute cellular rejection in a small intestinal transplant
por: Apostolov, Ross, et al.
Publicado: (2017) -
The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy
por: van der Zwan, Marieke, et al.
Publicado: (2018) -
Acute pancreatitis induced by mycophenolate mofetil in a kidney transplant patient
por: Einollahi, Behzad, et al.
Publicado: (2015) -
Comparison of azathioprine with mycophenolate mofetil in a living donor kidney transplant programme
por: Bansal, S. B., et al.
Publicado: (2011)